NDC 13533-684

Plasbumin

Albumin (human)

Plasbumin is a Intravenous Solution in the Plasma Derivative category. It is labeled and distributed by Grifols Usa, Llc. The primary component is Albumin Human.

Product ID13533-684_888a8731-bd85-4a5c-a67f-6b38efe1d58d
NDC13533-684
Product TypePlasma Derivative
Proprietary NamePlasbumin
Generic NameAlbumin (human)
Dosage FormSolution
Route of AdministrationINTRAVENOUS
Marketing Start Date1942-10-21
Marketing End Date2019-06-05
Marketing CategoryBLA / BLA
Application NumberBLA101138
Labeler NameGRIFOLS USA, LLC
Substance NameALBUMIN HUMAN
Active Ingredient Strength5 g/20mL
Pharm ClassesHuman Serum Albumin [EPC],Increased Intravascular Volume [PE],Increased Oncotic Pressure [PE],Osmotic Activity [MoA],Serum Albumin [Chemical/Ingredient]
NDC Exclude FlagN

Packaging

NDC 13533-684-71

1 VIAL in 1 CARTON (13533-684-71) > 100 mL in 1 VIAL (13533-684-72)
Marketing Start Date1942-10-21
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 13533-684-21 [13533068421]

Plasbumin SOLUTION
Marketing CategoryBLA
Application NumberBLA101138
Product TypePLASMA DERIVATIVE
Billing UnitML
Marketing Start Date2012-12-01
Marketing End Date2019-06-05

NDC 13533-684-20 [13533068420]

Plasbumin SOLUTION
Marketing CategoryBLA
Application NumberBLA101138
Product TypePLASMA DERIVATIVE
Billing UnitML
Marketing Start Date1942-10-21
Marketing End Date2019-06-05

NDC 13533-684-72 [13533068472]

Plasbumin SOLUTION
Marketing CategoryBLA
Application NumberBLA101138
Product TypePLASMA DERIVATIVE
Billing UnitML
Marketing Start Date2012-12-01
Marketing End Date2019-06-05

NDC 13533-684-16 [13533068416]

Plasbumin SOLUTION
Marketing CategoryBLA
Application NumberBLA101138
Product TypePLASMA DERIVATIVE
Billing UnitML
Marketing Start Date1942-10-21
Marketing End Date2019-06-05

NDC 13533-684-17 [13533068417]

Plasbumin SOLUTION
Marketing CategoryBLA
Application NumberBLA101138
Product TypePLASMA DERIVATIVE
Billing UnitML
Marketing Start Date2012-12-01
Marketing End Date2019-06-05

NDC 13533-684-71 [13533068471]

Plasbumin SOLUTION
Marketing CategoryBLA
Application NumberBLA101138
Product TypePLASMA DERIVATIVE
Billing UnitML
Marketing Start Date1942-10-21
Marketing End Date2019-06-05

Drug Details

Active Ingredients

IngredientStrength
ALBUMIN HUMAN5 g/20mL

Pharmacological Class

  • Human Serum Albumin [EPC]
  • Increased Intravascular Volume [PE]
  • Increased Oncotic Pressure [PE]
  • Osmotic Activity [MoA]
  • Serum Albumin [Chemical/Ingredient]

Medicade Reported Pricing

13533068471 PLASBUMIN-25 IV SOLUTION

Pricing Unit: ML | Drug Type:

NDC Crossover Matching brand name "Plasbumin" or generic name "Albumin (human)"

NDCBrand NameGeneric Name
13533-683PlasbuminAlbumin (Human)
13533-684PlasbuminAlbumin (Human)
13533-690PlasbuminAlbumin (Human)
13533-691PlasbuminAlbumin (Human)
13533-692PlasbuminAlbumin (Human)
0053-7680Albuminar-25Albumin (Human)
0053-7670Albuminar-5Albumin (Human)
44206-251AlbuRxALBUMIN (HUMAN)
44206-310ALBURXALBUMIN (HUMAN)
68516-5214ALBUTEINALBUMIN (HUMAN)
68516-5215ALBUTEINALBUMIN (HUMAN)
68516-5216ALBUTEINALBUMIN (HUMAN)
61953-0001HUMAN ALBUMIN GRIFOLSALBUMIN (HUMAN)
61953-0002HUMAN ALBUMIN GRIFOLSALBUMIN (HUMAN)

Trademark Results [Plasbumin]

Mark Image

Registration | Serial
Company
Trademark
Application Date
PLASBUMIN
PLASBUMIN
73197739 1136564 Live/Registered
CUTTER LABORATORIES, INC.
1978-12-21

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.